Close Menu


The amount of activity last year on the regulatory, reimbursement, legislative, educational, and intellectual property fronts is a sign that the wheels are slowly shifting toward creating a framework that will someday support and deliver genomically guided medicine, even though plenty of barriers and challenges need to be overcome on the path to that goal.

Despite advances, there remains much work to be done on the basic biology side of things if RNAi is ever to achieve its promise as a therapeutic modality, industry watchers said.

Independent research teams from the University of Washington and Stanford University have developed methods for doing direct haplotyping that employ large insert cloning and microfluidics, respectively.

Using chromatin immunoprecipitation sequencing, RNA sequencing, and other approaches, researchers from Stanford University have tracked down thousands of enhancers near genes that are inactive in human embryonic stem cells but which become active during early stages of development.

Simbios will use physical simulations to understand how drugs work and to study how neural activity ultimately generates movement.

IP Roundup: Nov 16, 2010


Panasonic, California Institute of Technology, Samsung Electronics, Children's Mercy Hospital, Affymetrix, Nanogen Recognomics, Stanford University

The assay, which is based on melt curve analysis, can currently detect and discriminate between nearly 40 important clinical bacterial species, and may eventually be able to test for more than 100 such species, according to the project's lead scientist.

The US Supreme Court will review a case in which Stanford University sued Roche for IP infringement, arguing federal legislation gives the school rights to PCR technology that was developed with NIH funds.

By compiling and analyzing data on thousands of disease-associated SNPs, a California research team has garnered evidence suggesting synonymous SNPs are as likely to be associated with disease as non-synonymous SNPs.

With the assay, the Stanford researchers have begun examining protein phosphorylation levels in a variety of cancer types. The team has also entered into collaborations with several pharmaceutical firms to investigate the effects of therapeutic agents on protein phosphorylation levels in tumor cells.


Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.